GALDY (Galderma Group AG) COGS-to-Revenue : 0.30 (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG COGS-to-Revenue?

Galderma Group AG's Cost of Goods Sold for the six months ended in Jun. 2024 was $667 Mil. Its Revenue for the six months ended in Jun. 2024 was $2,216 Mil.

Galderma Group AG's COGS to Revenue for the six months ended in Jun. 2024 was 0.30.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Galderma Group AG's Gross Margin % for the six months ended in Jun. 2024 was 69.90%.

Galderma Group AG COGS-to-Revenue Historical Data

The historical data trend for Galderma Group AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG COGS-to-Revenue Chart

Galderma Group AG Annual Data

Trend

COGS-to-Revenue

Galderma Group AG Semi-Annual Data
	Jun23	Jun24
COGS-to-Revenue	0.29	0.30

Galderma Group AG COGS-to-Revenue Calculation

Galderma Group AG's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Galderma Group AG's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	667	/	2216
	=	0.30

Galderma Group AG (OTCPK:GALDY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Galderma Group AG's Gross Margin % for the six months ended in Jun. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	667 / 2216
	=	69.90 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Galderma Group AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

GDERF:USA GALDz:UK PY30:Germany GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

From GuruFocus

GALDERMA LAUNCHES CETAPHIL GENTLE EXFOLIATING LINE WITH GEN-Z IT-GIRL KATIE FANG

By PRNewswire • 09-04-2024